ID   UBE3B_HUMAN             Reviewed;        1068 AA.
AC   Q7Z3V4; A5D8Z3; Q05BX9; Q659F7; Q7Z7Q1; Q9BXZ4;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   15-MAR-2017, entry version 118.
DE   RecName: Full=Ubiquitin-protein ligase E3B;
DE            EC=2.3.2.26;
DE   AltName: Full=HECT-type ubiquitin transferase E3B;
GN   Name=UBE3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RX   PubMed=12837265; DOI=10.1016/S0888-7543(03)00111-3;
RA   Gong T.-W.L., Huang L., Warner S.J., Lomax M.I.;
RT   "Characterization of the human UBE3B gene: structure, expression,
RT   evolution, and alternative splicing.";
RL   Genomics 82:143-152(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   GLN-346.
RC   TISSUE=Endometrial adenocarcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   GLN-346.
RC   TISSUE=Brain, Lung, Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-419, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   VARIANT KOS PRO-727.
RX   PubMed=23200864; DOI=10.1016/j.ajhg.2012.10.011;
RA   Basel-Vanagaite L., Dallapiccola B., Ramirez-Solis R., Segref A.,
RA   Thiele H., Edwards A., Arends M.J., Miro X., White J.K., Desir J.,
RA   Abramowicz M., Dentici M.L., Lepri F., Hofmann K., Har-Zahav A.,
RA   Ryder E., Karp N.A., Estabel J., Gerdin A.K., Podrini C., Ingham N.J.,
RA   Altmueller J., Nuernberg G., Frommolt P., Abdelhak S.,
RA   Pasmanik-Chor M., Konen O., Kelley R.I., Shohat M., Nuernberg P.,
RA   Flint J., Steel K.P., Hoppe T., Kubisch C., Adams D.J., Borck G.;
RT   "Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-
RT   ptosis-intellectual-disability syndrome.";
RL   Am. J. Hum. Genet. 91:998-1010(2012).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from
CC       an E2 ubiquitin-conjugating enzyme in the form of a thioester and
CC       then directly transfers the ubiquitin to targeted substrates.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=UBE3B_v1;
CC         IsoId=Q7Z3V4-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2; Synonyms=UBE3B_v2;
CC         IsoId=Q7Z3V4-2; Sequence=VSP_024087, VSP_024088;
CC       Name=3;
CC         IsoId=Q7Z3V4-3; Sequence=VSP_024085, VSP_024086;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:12837265}.
CC   -!- DISEASE: Kaufman oculocerebrofacial syndrome (KOS) [MIM:244450]: A
CC       syndrome characterized by blepharophimosis, ptosis, mild
CC       upslanting of the palpebral fissures, epicanthus, ectodermal
CC       anomalies, developmental delay, and severe intellectual disability
CC       with absent speech. Proportionate growth retardation with a small
CC       head circumference/microcephaly, congenital malformations,
CC       muscular hypotonia, anomalies on brain imaging with hypoplasia of
CC       the corpus callosum, and low cholesterol levels are variably
CC       present. {ECO:0000269|PubMed:23200864}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF251046; AAK28419.2; -; mRNA.
DR   EMBL; AL096740; CAH56410.1; -; mRNA.
DR   EMBL; BX537403; CAD97645.1; -; mRNA.
DR   EMBL; AC007570; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032301; AAH32301.1; -; mRNA.
DR   EMBL; BC051266; AAH51266.1; -; mRNA.
DR   EMBL; BC068221; AAH68221.1; -; mRNA.
DR   EMBL; BC108705; AAI08706.1; -; mRNA.
DR   EMBL; BC141880; AAI41881.1; -; mRNA.
DR   CCDS; CCDS58277.1; -. [Q7Z3V4-3]
DR   CCDS; CCDS9129.1; -. [Q7Z3V4-1]
DR   RefSeq; NP_001257378.1; NM_001270449.1. [Q7Z3V4-3]
DR   RefSeq; NP_001257379.1; NM_001270450.1. [Q7Z3V4-3]
DR   RefSeq; NP_001257380.1; NM_001270451.1. [Q7Z3V4-3]
DR   RefSeq; NP_569733.2; NM_130466.3. [Q7Z3V4-1]
DR   RefSeq; NP_904324.1; NM_183415.2. [Q7Z3V4-1]
DR   RefSeq; XP_005254044.1; XM_005253987.2. [Q7Z3V4-1]
DR   RefSeq; XP_011537261.1; XM_011538959.2. [Q7Z3V4-1]
DR   RefSeq; XP_016875685.1; XM_017020196.1. [Q7Z3V4-3]
DR   UniGene; Hs.374067; -.
DR   ProteinModelPortal; Q7Z3V4; -.
DR   SMR; Q7Z3V4; -.
DR   BioGrid; 124642; 8.
DR   IntAct; Q7Z3V4; 3.
DR   STRING; 9606.ENSP00000340596; -.
DR   iPTMnet; Q7Z3V4; -.
DR   PhosphoSitePlus; Q7Z3V4; -.
DR   BioMuta; UBE3B; -.
DR   DMDM; 296453010; -.
DR   EPD; Q7Z3V4; -.
DR   MaxQB; Q7Z3V4; -.
DR   PaxDb; Q7Z3V4; -.
DR   PeptideAtlas; Q7Z3V4; -.
DR   PRIDE; Q7Z3V4; -.
DR   DNASU; 89910; -.
DR   Ensembl; ENST00000340074; ENSP00000342614; ENSG00000151148. [Q7Z3V4-3]
DR   Ensembl; ENST00000342494; ENSP00000340596; ENSG00000151148. [Q7Z3V4-1]
DR   Ensembl; ENST00000434735; ENSP00000391529; ENSG00000151148. [Q7Z3V4-1]
DR   Ensembl; ENST00000449510; ENSP00000395802; ENSG00000151148. [Q7Z3V4-2]
DR   Ensembl; ENST00000536398; ENSP00000440585; ENSG00000151148. [Q7Z3V4-3]
DR   Ensembl; ENST00000540230; ENSP00000443565; ENSG00000151148. [Q7Z3V4-3]
DR   GeneID; 89910; -.
DR   KEGG; hsa:89910; -.
DR   UCSC; uc001tom.5; human. [Q7Z3V4-1]
DR   CTD; 89910; -.
DR   DisGeNET; 89910; -.
DR   GeneCards; UBE3B; -.
DR   H-InvDB; HIX0020836; -.
DR   H-InvDB; HIX0036751; -.
DR   H-InvDB; HIX0129665; -.
DR   HGNC; HGNC:13478; UBE3B.
DR   HPA; HPA041012; -.
DR   MalaCards; UBE3B; -.
DR   MIM; 244450; phenotype.
DR   MIM; 608047; gene.
DR   neXtProt; NX_Q7Z3V4; -.
DR   OpenTargets; ENSG00000151148; -.
DR   Orphanet; 329255; Blepharophimosis-intellectual disability syndrome due to UBE3B deficiency.
DR   Orphanet; 2707; Oculocerebrofacial syndrome, Kaufman type.
DR   PharmGKB; PA134872189; -.
DR   eggNOG; KOG0942; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   GeneTree; ENSGT00550000074668; -.
DR   HOGENOM; HOG000232154; -.
DR   HOVERGEN; HBG108644; -.
DR   InParanoid; Q7Z3V4; -.
DR   KO; K10588; -.
DR   OMA; FQSVHGW; -.
DR   OrthoDB; EOG091G029A; -.
DR   PhylomeDB; Q7Z3V4; -.
DR   TreeFam; TF313215; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE3B; human.
DR   GenomeRNAi; 89910; -.
DR   PRO; PR:Q7Z3V4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000151148; -.
DR   CleanEx; HS_UBE3B; -.
DR   ExpressionAtlas; Q7Z3V4; baseline and differential.
DR   Genevisible; Q7Z3V4; HS.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   CDD; cd00078; HECTc; 1.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   Pfam; PF00632; HECT; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00015; IQ; 1.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS50096; IQ; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Mental retardation; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation pathway.
FT   CHAIN         1   1068       Ubiquitin-protein ligase E3B.
FT                                /FTId=PRO_0000281882.
FT   DOMAIN       29     58       IQ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      702   1068       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   ACT_SITE   1036   1036       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00104}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     419    419       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   VAR_SEQ     211    244       ILLTRGLARPRPCLSKGTLTAAFSLALRPVIAAQ -> CCD
FT                                GLFPDLVSYAPHNNPVRWSVGRSWYDWQLSR (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_024085.
FT   VAR_SEQ     245   1068       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_024086.
FT   VAR_SEQ     693    708       DGYEQLRQLSQHAMKG -> SLFECPWPLVINAESC (in
FT                                isoform 2). {ECO:0000303|PubMed:12837265,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_024087.
FT   VAR_SEQ     709   1068       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12837265,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_024088.
FT   VARIANT     346    346       R -> Q (in dbSNP:rs7298565).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_031302.
FT   VARIANT     727    727       Q -> P (in KOS; dbSNP:rs398123023).
FT                                {ECO:0000269|PubMed:23200864}.
FT                                /FTId=VAR_069712.
FT   CONFLICT    151    151       E -> V (in Ref. 2; CAD97645).
FT                                {ECO:0000305}.
FT   CONFLICT    907    907       I -> V (in Ref. 2; CAD97645).
FT                                {ECO:0000305}.
FT   CONFLICT    942    942       Y -> H (in Ref. 2; CAD97645).
FT                                {ECO:0000305}.
FT   CONFLICT   1018   1018       F -> S (in Ref. 2; CAD97645).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1068 AA;  123098 MW;  A1740A3DDC5E1A4D CRC64;
     MFTLSQTSRA WFIDRARQAR EERLVQKERE RAAVVIQAHV RSFLCRSRLQ RDIRREIDDF
     FKADDPESTK RSALCIFKIA RKLLFLFRIK EDNERFEKLC RSILSSMDAE NEPKVWYVSL
     ACSKDLTLLW IQQIKNILWY CCDFLKQLKP EILQDSRLIT LYLTMLVTFT DTSTWKILRG
     KGESLRPAMN HICANIMGHL NQHGFYSVLQ ILLTRGLARP RPCLSKGTLT AAFSLALRPV
     IAAQFSDNLI RPFLIHIMSV PALVTHLSTV TPERLTVLES HDMLRKFIIF LRDQDRCRDV
     CESLEGCHTL CLMGNLLHLG SLSPRVLEEE TDGFVSLLTQ TLCYCRKYVS QKKSNLTHWH
     PVLGWFSQSV DYGLNESMHL ITKQLQFLWG VPLIRIFFCD ILSKKLLESQ EPAHAQPASP
     QNVLPVKSLL KRAFQKSASV RNILRPVGGK RVDSAEVQKV CNICVLYQTS LTTLTQIRLQ
     ILTGLTYLDD LLPKLWAFIC ELGPHGGLKL FLECLNNDTE ESKQLLAMLM LFCDCSRHLI
     TILDDIEVYE EQISFKLEEL VTISSFLNSF VFKMIWDGIV ENAKGETLEL FQSVHGWLMV
     LYERDCRRRF TPEDHWLRKD LKPSVLFQEL DRDRKRAQLI LQYIPHVIPH KNRVLLFRTM
     VTKEKEKLGL VETSSASPHV THITIRRSRM LEDGYEQLRQ LSQHAMKGVI RVKFVNDLGV
     DEAGIDQDGV FKEFLEEIIK RVFDPALNLF KTTSGDERLY PSPTSYIHEN YLQLFEFVGK
     MLGKAVYEGI VVDVPFASFF LSQLLGHHHS VFYSSVDELP SLDSEFYKNL TSIKRYDGDI
     TDLGLTLSYD EDVMGQLVCH ELIPGGKTIP VTNENKISYI HLMAHFRMHT QIKNQTAALI
     SGFRSIIKPE WIRMFSTPEL QRLISGDNAE IDLEDLKKHT VYYGGFHGSH RVIIWLWDIL
     ASDFTPDERA MFLKFVTSCS RPPLLGFAYL KPPFSIRCVE VSDDQDTGDT LGSVLRGFFT
     IRKREPGGRL PTSSTCFNLL KLPNYSKKSV LREKLRYAIS MNTGFELS
//
